Reata Pharmaceuticals RETA
$ 172.36
0.0%
Quarterly report 2023-Q1
added 05-10-2023
Country |
USA |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. J. Warren Huff |
Employees in the company |
220 |
Shares |
36.5 M |
Market Cap[1] |
$ 6.29 B |
EBITDA (LTM) |
$ 1.14 M |
P/E (LTM) |
-9.67 |
P/S (LTM) |
1406.99 |
EPS (LTM) |
-9.35 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.